Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.
Weber F, Asher A, Bucholz R, Berger M, Prados M, Chang S, Bruce J, Hall W, Rainov NG, Westphal M, Warnick RE, Rand RW, Floeth F, Rommel F, Pan H, Hingorani VN, Puri RK.
Weber F, et al. Among authors: chang s.
J Neurooncol. 2003 Aug-Sep;64(1-2):125-37. doi: 10.1007/BF02700027.
J Neurooncol. 2003.
PMID: 12952293
Clinical Trial.